BIOX: Jasper Lake's 10.6% Stake via $33.5M Convertible Note

Q: What stake did Jasper Lake and Noah Kolatch report in BIOX?

They reported beneficial ownership of 7,382,919 Ordinary Shares , approximately 10.6% of the class based on the filing's calculation.

Q: How is the 7,382,919-share position composed?

It consists of 397,000 Ordinary Shares held by Jasper Lake plus 6,985,919 Ordinary Shares issuable upon conversion of the Notes as stated in the filing.

Q: How much did Jasper Lake invest in the Notes?

Jasper Lake purchased $33,500,000 in principal amount of a Secured Guaranteed Convertible Note under the Purchase Agreement.

Q: What are the key economic terms of the Notes?

The Notes bore 9.00% interest through June 15, 2025 and 15.00% thereafter, mature on August 31, 2027 , and are convertible into Ordinary Shares using a Strike Price originally equal to $6.00 subject to adjustments.

Q: When can the Notes be converted into Ordinary Shares?

The Notes are convertible at the holders' option after September 30, 2025 , and the filing notes the reported number of issuable shares is convertible within 60 days of this Schedule 13D as presented.

Q: Did the Reporting Persons receive board representation?

Yes. Pursuant to an amendment, Noah Kolatch was appointed to the Issuer's Board and the Issuer also appointed Scott Croco and Milen Marinov , with replacement-nomination rights described in the amendment.

[SCHEDULE 13D] Bioceres Crop Solutions Corp. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

SCHEDULE 13D

Rhea-AI Filing Summary

Jasper Lake Ventures One LLC and Noah Kolatch report a combined economic interest of 7,382,919 ordinary shares in Bioceres Crop Solutions Corp. (BIOX), representing approximately 10.6% of the outstanding class on the calculation in this filing. That position includes 397,000 Ordinary Shares held directly by Jasper Lake plus the Ordinary Shares issuable upon conversion of a secured guaranteed convertible Note into 6,985,919 Ordinary Shares as of this filing.

The Notes were purchased under a Note Purchase Agreement as part of a $55,000,000 issuance, with Jasper Lake acquiring $33,500,000 in principal. The Notes bore regular interest at 9.00% per year until June 15, 2025 and 15.00% thereafter, mature on August 31, 2027, and are convertible into Ordinary Shares using a Strike Price originally equal to $6.00 subject to customary anti-dilution adjustments and price-based reductions in certain financings. PIK interest accrues and compounds, increasing the Accreted Principal Amount and the number of shares issuable on conversion.

Under an amendment, Noah Kolatch was appointed to the Issuer's Board and the Issuer also appointed Scott Croco and Milen Marinov; replacement-nomination rights for certain directors are described. The Reporting Persons state the acquisition was for investment purposes, note registration rights were granted, and disclose they may engage with management or consider actions including acquiring or disposing of securities, hedging, or proposing strategic alternatives.

Jasper Lake Ventures One LLC鞕€ Noah Kolatch電� Bioceres Crop Solutions Corp.(BIOX)鞚� 氤错喌欤� 7,382,919欤检棎雽€頃� 瓿惦彊瓴届牅鞝� 鞚错暣甏€瓿勲ゼ鞁犼碃頄堨溂氅�, 鞚措姅氤� 鞝滌稖靹滊鞚� 瓿勳偘鞐� 霐半澕氚滍枆欤检嫕鞚� 鞎� 10.6%鞐� 頃措嫻頃╇媹雼�. 鞚� 歆€攵勳棎電� Jasper Lake臧€ 歆侅爲氤挫湢頃� 397,000欤检檧, 氤� 鞝滌稖鞚� 順勳灛雼措炒氤挫順� 鞝勴櫂靷眲鞚� 鞝勴櫂鞙茧 氚滍枆霅� 靾� 鞛堧姅 6,985,919欤缄皜韽暔霅╇媹雼�.

頃措嫻毂勱秾(Notes)鞚€ Note Purchase Agreement鞐� 霐半澕齑� $55,000,000 攴滊鞚� 氚滍枆鞚� 鞚柬櫂鞙茧 毵れ垬霅橃棃鞙茧┌, Jasper Lake電� $33,500,000鞚� 鞗愱笀鞚� 鞚胳垬頄堨姷雼堧嫟. 毂勱秾鞚€ 2025雲� 6鞗� 15鞚缄箤歆€ 鞐瓣皠 9.00%鞚� 韱奠儊鞚挫瀽毳� 歆€旮夗晿瓿� 鞚错泟鞐愲姅 15.00%搿� 鞝侅毄霅橂┌, 毵岅赴電� 2027雲� 8鞗� 31鞚检澊瓿� 鞗愲灅頄夓偓臧€瓴╈澊 $6.00鞚� 臁瓣贝鞙茧 氤错喌欤茧 鞝勴櫂臧€電ロ暕雼堧嫟(韱奠儊鞝侅澑頋劃氚╈ 臁办爼氚� 韸轨爼鞛愱笀臁半嫭鞁� 臧€瓴� 旮办 臧愳暋鞝侅毄). 鞚挫瀽歆€旮� 雽€鞁� 欤检嫕鞙茧 雽€觳措悩電� PIK 鞚挫瀽電� 氚滌儩頃橃棳氤惦Μ搿� 雸勳爜霅橂┌, 雸勳爜鞗愱笀鞎￡臣鞝勴櫂鞁� 氚滍枆臧€電ロ暅欤检嫕靾橂ゼ歃濌皜鞁滍偟雼堧嫟.

臧滌爼鞎堨棎霐半澕 Noah Kolatch臧€ 氚滍枆須岇偓鞚� 鞚挫偓須岇棎鞛勲獏霅橃棃瓿�, 氚滍枆須岇偓霃� Scott Croco鞕€ Milen Marinov毳� 鞛勲獏頄堨姷雼堧嫟; 韸轨爼鞚挫偓霌れ棎雽€頃� 甑愳泊路歆€氇� 甓岆Μ臧€ 靹る獏霅橃柎鞛堨姷雼堧嫟. 氤搓碃鞚胳潃頃措嫻鞚胳垬臧€ 韴瀽氇╈爜鞛勳潉氚濏瀳瓿�, 毂勱秾鞐� 雽€頃� 霌彪 甓岆Μ臧€ 攵€鞐悩鞐堨潓鞚� 氇呾嫓頃橂┌, 瓴届榿歆勱臣鞚� 甑愳劖霕愲姅鞙犼皜歃濌秾鞚� 毵れ垬路毵る弰, 項れ 瓯半灅, 鞝勲灥鞝� 雽€鞎� 鞝滌晥霌� 雼れ枒頃� 臁办箻毳� 瓿犽牑頃� 靾� 鞛堨潓鞚� 瓿店皽頃╇媹雼�.

Positive

7,382,919 Ordinary Shares beneficial interest reported, representing approximately 10.6% of the class.
Jasper Lake acquired $33,500,000 in principal of the convertible Note, part of a $55,000,000 issuance.
Appointment of Noah Kolatch to the Issuer's Board and appointment of Scott Croco and Milen Marinov formalizes governance access tied to the financing.
Holders were granted registration rights with respect to the underlying Ordinary Shares, facilitating potential future liquidity.

Negative

The Notes include price-based anti-dilution provisions that may reduce the Strike Price if the Issuer issues shares below the then-prevailing Strike Price, potentially increasing dilution.
Accreted principal and PIK interest increase the number of shares issuable on conversion, diluting existing shareholders if conversion occurs.
The Notes' interest rate increases from 9.00% to 15.00% after June 15, 2025, which raises the Accreted Principal Amount and could further raise conversion share count under the stated mechanics.

Insights

TL;DR: Jasper Lake holds a meaningful convertible position (10.6%) and secured board representation via negotiated amendments.

Jasper Lake's economic exposure of 7,382,919 shares, driven by a $33.5M principal convertible note position that converts into 6,985,919 shares as reported, represents a material financing-based stake. The note economics 鈥� 9% interest transitioning to 15% and PIK accrual 鈥� increase the accreted principal that determines conversion share count. The presence of specified anti-dilution and price-based protections can materially alter the Strike Price and outstanding share count if future financings occur below that price. Board appointments formalize governance access, which combined with registration rights, gives the reporting persons mechanisms to influence capital-related outcomes.

TL;DR: Reporting persons secured governance access but describe their purpose as primarily investment-oriented; disclosures are typical for convertible financings.

The amendment that appoints Noah Kolatch and adds two other directors is a clear governance term tied to the financing. The filing discloses nomination and replacement-selection mechanics for directors during the Restricted Period, a contractual governance arrangement explicitly tied to the Notes. The Reporting Persons state an investment purpose and reserve the right to engage with management or pursue strategic actions, but do not present current plans to effectuate specific corporate transactions. From a governance perspective, the arrangement is material and standard for holders of sizable convertible positions.

08/08/2025 - 05:00 PM

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Bioceres Crop Solutions Corp.

(Name of Issuer)

Ordinary Shares, par value $0.0001

(Title of Class of Securities)

G1117K114

(CUSIP Number)

Noah Kolatch
930 Sylvan Avenue, Suite 140
Englewood Cliffs, NJ, 07632
(786) 688-2201

Greg Kramer
30 Rockefeller Plaza, 26th Floor
New York, NY, 10112
(212) 835-4819

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

08/01/2025

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 搂搂 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No.

G1117K114

Name of reporting person

Jasper Lake Ventures One LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 7,382,919.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 7,382,919.00

Aggregate amount beneficially owned by each reporting person

7,382,919.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Percent of class represented by amount in Row (11)

10.6 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

The number of shares in rows 8, 10 and 11 consists of 397,000 Ordinary Shares held by Jasper Lake as of the filing of this Schedule 13D plus the Ordinary Shares issuable upon the conversion of the Notes held by Jasper Lake. The percentage set forth in Row 13 is calculated based on (i) 62,712,602 Ordinary Shares of the Issuer outstanding as of March 31, 2025, as reported in the Issuer's current report on Form 6-K filed with the Commission on June 20, 2025, plus (ii) 6,985,919 Ordinary Shares issuable upon the conversion of the Note, which is convertible within 60 days of this Schedule 13D.

SCHEDULE 13D

CUSIP No.

G1117K114

Name of reporting person

Noah Kolatch

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 7,382,919.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 7,382,919.00

Aggregate amount beneficially owned by each reporting person

7,382,919.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Percent of class represented by amount in Row (11)

10.6 %

Type of Reporting Person (See Instructions)

IN, HC

Comment for Type of Reporting Person:

The number of shares in Rows 8, 10 and 11 consists of 397,000 Ordinary Shares held by Jasper Lake as of the filing of this Schedule 13D plus the Ordinary Shares issuable upon the conversion of the Notes held by Jasper Lake. The percentage set forth in Row 13 is calculated based on (i) 62,712,602 Ordinary Shares of the Issuer outstanding as March 31, 2025, as reported in the Issuer's current report on Form 6-K filed with the Commission on June 20, 2025, plus (ii) 6,985,919 Ordinary Shares issuable upon the conversion of the Notes, which is convertible within 60 days of this Schedule 13D.

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Ordinary Shares, par value $0.0001

(b)

Name of Issuer:

Bioceres Crop Solutions Corp.

(c)

Address of Issuer's Principal Executive Offices:

Ocampo 210 bis, Predio CCT, Rosario, ARGENTINA , 2000.

Item 1 Comment:

Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

Item 2.

Identity and Background

(a)

The persons filing this Schedule 13D (collectively, the "Reporting Persons") are Jasper Lake Ventures One LLC ("Jasper Lake") and Noah Kolatch.

(b)

The principal business address of each of the Reporting Persons is 930 Sylvan Avenue, Suite 140, Englewood Cliffs, NJ 07632.

(c)

Jasper Lake is principally engaged in investing. Each of Noah Kolatch, Jonathan Kolatch and Joseph Kolatch is a principal of Jasper Lake and Noah Kolatch is a Director of the Issuer. Each of them may be deemed to share voting and dispositive power with respect to the securities of Issuer held by Jasper Lake. Voting and investment decisions with respect to securities held by Jasper Lake are made by the managers of Jasper Lake. Each of the Reporting Persons may also serve as general partner, principal or manager of certain other entities engaged in the purchasing, holding, and selling of securities for investment purposes.

(d)

During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e)

During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgement, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f)

Jasper Lake - Delaware Noah Kolatch - United States of America

Item 3.

Source and Amount of Funds or Other Consideration

This Schedule 13D relates to Ordinary Shares that the Reporting Persons have the right to acquire within 60 days upon conversion of the Secured Guaranteed Convertible Note (the "Note" and part of a series of identical "Notes" issued pursuant to the Purchase Agreement (as defined below)) held directly by Jasper Lake. As further described below, Jasper Lake used a total of approximately $33,500,000 to acquire the Notes (including the right to convert such Notes into Ordinary Shares in accordance with the terms of such Notes) reported in this Schedule 13D. The source of the funds used to acquire the Notes (and the Ordinary Shares into which such Notes may be converted) reported herein is the investment capital of Jasper Lake. On August 5, 2022, Jasper Lake entered into a Note Purchase Agreement with the Issuer and the other parties thereto (as amended as of June 18, 2025, the "Purchase Agreement"), pursuant to which Jasper Lake agreed to purchase $33,500,000 in principal amount of a Note. On August 5, 2022 (the "Issue Date"), the Issuer issued $55,000,000 in aggregate principal amount of Notes (including the Note purchased by Jasper Lake) pursuant to the Purchase Agreement. The Notes bore regular interest at a rate of 9.00% per year from the Issue Date, until and through June 15, 2025. From and after June 16, 2025, the Notes bear a regular interest rate of 15.00% per annum. The Notes will mature on August 31, 2027, unless earlier redeemed, repurchased or converted in accordance with the terms of the Notes. The Notes are convertible at the option of the holders at any time after September 30, 2025, into that number of Ordinary Shares, calculated by dividing (x) the principal amount of the Note then outstanding plus the amount of PIK interest accrued thereon and compounded thereto (the "Accreted Principal Amount") by (y) a strike price originally equal to $6.00, as may be adjusted in accord with the terms and conditions of the Purchase Agreement (the "Strike Price"). As such, the Note held by Jasper Lake was, as of the date of this Schedule 13D, convertible into an aggregate of 6,985,919 Ordinary Shares. The number of Ordinary Shares issuable upon conversion of the Note will increase a result of PIK interest accrued and compounded thereon as of the date of any conversion. In addition, each holder of a Note, including Jasper Lake, also has the right to convert all or any portion of the Accreted Principal Amount of its Note together with any accrued and unpaid interest thereon, including the amount of the Prepayment Premium (as defined in the Purchase Agreement) (if any) and the Equity Option Fee (as defined in the Purchase Agreement) (if any) (such amounts collectively, the "CoC Conversion Amount") into that number of Ordinary Shares, calculated by dividing (x) the CoC Conversion Amount by (y) a strike price originally equal to the Strike Price. The Strike Price is subject to customary anti-dilution adjustments for stock splits, recapitalizations, reclassifications, reorganizations and similar events. The Strike Price is also subject to price based anti-dilution, including in the event that the Issuer consummates any issuances of Ordinary Shares or other securities that by their terms are convertible into or exchangeable for Ordinary Shares in an single transaction or series of related transactions in which the Issuer receives gross proceeds in excess of $10,000,000 at a price per Ordinary Share below the then prevailing Strike Price, then following such issuance the Strike Price shall be reduced to the price per share at which such Ordinary Shares are issued or may be converted or exercised. The Issuer has the right to prepay the Notes in accordance with the terms set forth in the Note Purchase Agreement. In connection with the Purchase Agreement and the issuance of the Notes, on the Issue Date, the Issuer entered into a Registration Rights Agreement with Jasper Lake and the other parties thereto (the "Registration Rights Agreement"), pursuant to which, among other things, the parties, including Jasper Lake, were granted customary registration rights with respect to the Ordinary Shares underlying the Notes. On June 18, 2025, the Issuer and the holders of the Notes, including Jasper Lake, entered into a First Amendment to Note Purchase Agreement and the Notes (the "Amendment"). Pursuant to the Amendment, Noah Kolatch was appointed to the Board of Directors of the Issuer (the "Board"). The initial term of Mr. Kolatch (or anyone who replaces him during such initial term) shall be until the Issuer's 2025 Annual General Meeting. Thereafter, at any time during the period that the Notes are outstanding (the "Restricted Period"), the Issuer shall cause Mr. Kolatch (or anyone who replaces him) to be nominated for election as a director by the Issuer's shareholders at the Issuer's Annual General Meeting, beginning with the Issuer's 2025 Annual General Meeting and at each annual meeting thereafter during the Restricted Period. In addition, as part of the Amendment, the Issuer appointed Scott Croco and Milen Marinov to the Board. In the event that Scott Croco is unable for any reason to serve as a director at any time during the Restricted Period, Noah Kolatch shall be entitled to select his replacement. If Milen Marinov is unable for any reason to serve as a director at any time during the Restricted Period, then Noah Kolatch and Scott Croco shall be entitled to select his replacement, provided that such replacement shall be reasonably acceptable to the other members of the Board. The foregoing is a summary description of certain terms of the Purchase Agreement (including the Amendment and the exhibits and attachments thereto) does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, which is filed as Exhibit 99.2 hereto, the Amendment, which is filed as Exhibit 99.3 hereto, and the Registration Rights Agreement, which is filed as Exhibit 99.4 hereto, each of which is incorporated herein by reference

Item 4.

Purpose of Transaction

The information in Item 3 of this Schedule 13D is incorporated by reference into this Item 4. The Reporting Persons acquired the Notes (and the Ordinary Shares into which such Notes may be converted) for investment purposes in Jasper Lake's ordinary course of business. The Reporting Persons have had discussions with members of the Issuer's management and members of the Issuer's Board in connection with the Reporting Persons' investment in the Issuer and Noah Kolatch's membership on the Board and may from time to time have further discussions with directors and officers of the Issuer, or discussions with other shareholders or third parties regarding the Issuer's business operations, strategies, capital structure, assets, liabilities and other matters related to the Issuer. The Reporting Persons, including as a member of the Board, may engage in a number of conversations that may relate to one or more of the items in subsections (a) through (j) of Item 4 of Schedule 13D, including options for maximizing shareholder value, enhancing the Issuer's corporate governance, improving capital, asset or liability allocation, monetizing the Issuer's assets, various strategic alternatives or operational or management initiatives, and the other Reporting Persons may also participate in those conversations as investors. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may from time to time and at any time in the future depending on various factors, including, without limitation, the Issuer's financial position and strategic direction, actions taken by the Board, price levels of the Issuer's securities, other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, take such actions with respect to the investment in the Issuer as they deem appropriate. Subject to the Issuer's insider trading policy, these actions may include: (i) acquiring additional Ordinary Shares and/or other equity, notes, other securities, derivatives or other instruments that are based upon or relate to the value of securities of the Issuer, or any debt of the Issuer or its affiliates, irrespective of whether it is a security (collectively, "Instruments") in the open market or otherwise; (ii) disposing of any or all of their Instruments in the open market or otherwise; (iii) engaging in any hedging or similar transactions with respect to the Instruments; or (iv) proposing or considering one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D. Except as described in this Schedule 13D, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, although, subject to the agreements described herein, the Reporting Persons, at any time and from time to time, may review, reconsider and change their position and/or change their purpose and/or develop such plans and may seek to influence management or the Board with respect to the business and affairs of the Issuer and may from time to time consider pursuing or proposing such matters with advisors, the Issuer or other persons. Although the foregoing reflects plans and proposals presently contemplated by each Reporting Person with respect to the Issuer, the foregoing is subject to change at any time and is dependent upon contingencies and assumed and speculative conditions, and there can be no assurance that any of the actions set forth above will be taken.

Item 5.

Interest in Securities of the Issuer

(a)

Each Reporting Person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act. Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act) with any other person as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any syndicate or group with respect to the Issuer or any securities of the Issuer. Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference. The percentages set forth herein are calculated based on (i) 62,712,602 Ordinary Shares of Bioceres Crop Solutions Corp. (the "Issuer") outstanding as March 31, 2025, as reported in the Issuer's current report on Form 6-K filed with the U.S. Securities and Exchange Commission (the "Commission") on June 20, 2025, plus 6,985,919 Ordinary Shares that the Reporting Persons currently have the right to acquire within 60 days upon conversion of the Notes.

(b)

As of August 1, 2025, the Reporting Persons held or had a right to receive an aggregate of 7,382,919 Ordinary Shares of the Issuer, which constitutes approximately 10.6% of the outstanding Ordinary Shares of the Issuer. Number of shares as to which each Reporting Person has: (i) sole power to vote or to direct the vote: See Item 7 on the cover pages hereto. (ii) shared power to vote or to direct the vote: See Item 8 on the cover pages hereto. (iii) sole power to dispose or to direct the disposition of: See Item 9 on the cover pages hereto. (iv) shared power to dispose or to direct the disposition of: See Item 10 on the cover pages hereto. Each of Noah Kolatch, Jonathan Kolatch, and Joseph Kolatch as a principal of Jasper Lake may be deemed to exercise voting and investment power over the Ordinary Shares directly held by Jasper Lake (including Ordinary Shares into which the Note may be converted). Each of them disclaims beneficial ownership over all securities beneficially owned by Jasper Lake, other than for the purpose of determining obligations under the Exchange Act, and the filing of this Schedule 13D shall not be deemed an admission that any of them is the beneficial owner of such securities for any other purpose.

(c)

Except as disclosed in this Schedule 13D, no transactions in the Ordinary Shares or securities convertible into, exercisable for, or exchangeable for Ordinary Shares were effected during the past sixty days by the Reporting Persons.

(d)

Except as otherwise described in this Item 5, no one other than the Reporting Persons has the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, any of the Ordinary Shares beneficially owned by the Reporting Persons as described in this Item 5.

(e)

Not applicable.

Item 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

The information in Items 3 and 4 of this Schedule 13D is incorporated by reference into this Item 6. Joint Filing Agreement Pursuant to Rule 13d-1(k) promulgated under the Exchange Act, the Reporting Persons have entered into a Joint Filing Agreement with respect to the joint filing of this statement and any amendments hereto, a copy of which is filed as Exhibit 99.1 hereto. Except as otherwise described herein, including the Notes and the Joint Filing Agreement, no Reporting Person has any contract, arrangement, understanding, or relationship with any person with respect to the Ordinary Shares of the Issuer or any other securities of the Issuer.

Item 7.

Material to be Filed as Exhibits.

The following exhibits are filed as exhibits hereto: Exhibit 99.1 Joint Filing Agreement by and among the Reporting Persons dated August 8, 2025 (filed herewith). Exhibit 99.2 Purchase Agreement, dated as of August 5, 2022 (incorporated herein by reference to the Note Purchase Agreement attached as Exhibit 99.10 of the Issuer's current report on Form 6-K filed with the Commission on August 8, 2022). Exhibit 99.3 Amendment, dated as of June 18, 2025 (incorporated herein by reference to the First Amendment to Note Purchase Agreement and the Convertible Notes attached as Exhibit 99.1 of the Issuer's current report on Form 6-K filed with the Commission on June 20, 2025). Exhibit 99.4 Registration Rights Agreement, dated as of August 5, 2022 (incorporated herein by reference to the Registration Rights Agreement attached as Exhibit 4.14 of the Issuer's annual report on Form 20-F filed with the Commission on October 28, 2022).

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Jasper Lake Ventures One LLC

Signature:	/s/ Noah Kolatch
Name/Title:	Noah Kolatch, Authorized Signatory
Date:	08/08/2025

Noah Kolatch

Signature:	/s/ Noah Kolatch
Name/Title:	NOAH KOLATCH
Date:	08/08/2025

Source:

FAQ

What stake did Jasper Lake and Noah Kolatch report in BIOX?

They reported beneficial ownership of 7,382,919 Ordinary Shares, approximately 10.6% of the class based on the filing's calculation.

How is the 7,382,919-share position composed?

It consists of 397,000 Ordinary Shares held by Jasper Lake plus 6,985,919 Ordinary Shares issuable upon conversion of the Notes as stated in the filing.

How much did Jasper Lake invest in the Notes?

Jasper Lake purchased $33,500,000 in principal amount of a Secured Guaranteed Convertible Note under the Purchase Agreement.

What are the key economic terms of the Notes?

The Notes bore 9.00% interest through June 15, 2025 and 15.00% thereafter, mature on August 31, 2027, and are convertible into Ordinary Shares using a Strike Price originally equal to $6.00 subject to adjustments.

When can the Notes be converted into Ordinary Shares?

The Notes are convertible at the holders' option after September 30, 2025, and the filing notes the reported number of issuable shares is convertible within 60 days of this Schedule 13D as presented.

Did the Reporting Persons receive board representation?

Yes. Pursuant to an amendment, Noah Kolatch was appointed to the Issuer's Board and the Issuer also appointed Scott Croco and Milen Marinov, with replacement-nomination rights described in the amendment.

AG真人官方

[SCHEDULE 13D] Bioceres Crop Solutions Corp. SEC Filing

Insights

FAQ

What stake did Jasper Lake and Noah Kolatch report in BIOX?

How is the 7,382,919-share position composed?

How much did Jasper Lake invest in the Notes?

What are the key economic terms of the Notes?

When can the Notes be converted into Ordinary Shares?

Did the Reporting Persons receive board representation?

NASDAQ:BIOX

BIOX Rankings

BIOX Latest News

BIOX Latest SEC Filings

BIOX Stock Data

AG真人官方

Trending News

[SCHEDULE 13D] Bioceres Crop Solutions Corp. SEC Filing

Insights

Financial Analyst positive

Corporate Governance Expert neutral

FAQ

What stake did Jasper Lake and Noah Kolatch report in BIOX?

How is the 7,382,919-share position composed?

How much did Jasper Lake invest in the Notes?

What are the key economic terms of the Notes?

When can the Notes be converted into Ordinary Shares?

Did the Reporting Persons receive board representation?

NASDAQ:BIOX

BIOX Rankings

BIOX Latest News

BIOX Latest SEC Filings

BIOX Stock Data